Skip to search formSkip to main contentSkip to account menu

Autologous Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes

Known as: EBV-Specific Cytotoxic T-Lymphocytes, Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes 
A preparation of lymphocytes harvested from a patient with an Epstein-Barr virus (EBV)-positive tumor. Ex vivo, the lymphocytes are activated against… 
National Institutes of Health

Related topics

Related topics

7 relations
Antigen SensitizationCytotoxic T-LymphocytesEpstein-Barr Virus InfectionsLMP2A-Specific Cytotoxic T-Lymphocytes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
EBV-Related Lymphomas: New Approaches to Treatment
Opinion statementIn the treatment of Epstein-Barr virus (EBV)-related lymphomas, there are few therapies specifically targeted… 
2007
2007
Successful treatment of lymphoproliferative disease complicating primary immunodeficiency/immunodysregulatory disorders with reduced-intensity allogeneic stem-cell transplantation.
Lymphoproliferative disease (LPD) is a recognized complication of primary immunodeficiency (PID) and immunodysregulatory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)